Quick Answer
TriSalus Life Sciences, Inc. reported Long Term Debt of $33.05 million for the year ending 2025.
- TriSalus Life Sciences, Inc. showed an increase of +49.6% in Long Term Debt from 2024 to 2025.
- This data is from TriSalus Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2024: $21.29 million | Q3 2024: $21.68 million | Q1 2025: $31.70 million | Q2 2025: $32.27 million | Q3 2025: $32.76 million.
- Historical annual values: Fiscal year 2025: $33.05 million | Fiscal year 2024: $22.08 million | Fiscal year 2023: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: